Cite
HARVARD Citation
Monin, L. et al. (2021). Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study. Lancet oncology. 22 (6), pp. 765-778. [Online].